Cargando…

Case report: Incidence and prognostic value of brain MRI lesions and elevated cerebrospinal fluid protein in children with Guillain-Barré syndrome

BACKGROUND: Guillain-Barrè syndrome (GBS) is an acute immune-mediated disorder affecting peripheral nerves and nerve roots with a variable clinical course and outcome. Epidemiologic analyses have revealed that the incidence of the syndrome increases linearly among the age. The clinical diagnosis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Pizzo, Francesco, Di Nora, Alessandra, Di Mari, Alessia, Costanza, Giuseppe, Testa, Elisabetta, Strazzieri, Marianna, Greco, Filippo, Timpanaro, Tiziana, Basile, Antonio, Belfiore, Giuseppe, Giugno, Andrea, Rocca, Roberta, Ruggieri, Martino, Fiumara, Agata, Pavone, Piero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635623/
https://www.ncbi.nlm.nih.gov/pubmed/36341115
http://dx.doi.org/10.3389/fneur.2022.885897
_version_ 1784824748202524672
author Pizzo, Francesco
Di Nora, Alessandra
Di Mari, Alessia
Costanza, Giuseppe
Testa, Elisabetta
Strazzieri, Marianna
Greco, Filippo
Timpanaro, Tiziana
Basile, Antonio
Belfiore, Giuseppe
Giugno, Andrea
Rocca, Roberta
Ruggieri, Martino
Fiumara, Agata
Pavone, Piero
author_facet Pizzo, Francesco
Di Nora, Alessandra
Di Mari, Alessia
Costanza, Giuseppe
Testa, Elisabetta
Strazzieri, Marianna
Greco, Filippo
Timpanaro, Tiziana
Basile, Antonio
Belfiore, Giuseppe
Giugno, Andrea
Rocca, Roberta
Ruggieri, Martino
Fiumara, Agata
Pavone, Piero
author_sort Pizzo, Francesco
collection PubMed
description BACKGROUND: Guillain-Barrè syndrome (GBS) is an acute immune-mediated disorder affecting peripheral nerves and nerve roots with a variable clinical course and outcome. Epidemiologic analyses have revealed that the incidence of the syndrome increases linearly among the age. The clinical diagnosis of GBS is based on the family history, physical and neurological examination, electrodiagnostic exams, and cerebrospinal fluid analysis with the classical presence of albumin-cytologic dissociation. Prognosis is associated with the severity of clinical signs and the type of peripheral nerves involved. METHODS: This study aims to clarify which clinical features can be used for prognostic purposes. We evaluated the correlation between (1) brain MRI lesions and grade of disability; (2) brain MRI lesions and elevated cerebrospinal fluid (CSF) protein; and (3) increased levels of CSF protein and grade of disability. Statistical analysis extracted from these data indicated a good correlation to be a prognostic indicator in children affected by GBS. We found little evidence regarding laboratory tests, imaging, and prognosis. We enrolled 12 continuous patients who met the Brighton criteria for GBS in this retrospective study. Each patient was clinically evaluated at the time of disease onset to assess the GBS disability score and after 2 weeks. RESULTS: We estimated Pearson's correlation index to evaluate the possible correlation between MRI and disability and CSF protein levels and disability. The correlation coefficient was 0.92 and 0.85, respectively. In addition, we developed a graph to see the trend of the disability values, proteins in the CSF, and damage assessed with MRI in the 12 patients. It seems that these parameters have a parallel trend and a good correlation in each patient. Finally, we calculated the correlation between MRI and CSF protein values, with an r-value of 0.87. The values suggest a correlation among the MRI score, CSF protein, and prognosis. CONCLUSION: The MRI and CSF laboratory parameters can be important tools for the clinician not only for diagnosis but also to evaluate the possible worsening of general conditions or the need to prepare measures to support life parameters. Patients who need ventilatory support could be established early from patients who have less severe GBS and can begin rehabilitation earlier. We suggest MRI should be performed routinely in children with GBS to be able to estimate the evolution of the clinical condition.
format Online
Article
Text
id pubmed-9635623
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96356232022-11-05 Case report: Incidence and prognostic value of brain MRI lesions and elevated cerebrospinal fluid protein in children with Guillain-Barré syndrome Pizzo, Francesco Di Nora, Alessandra Di Mari, Alessia Costanza, Giuseppe Testa, Elisabetta Strazzieri, Marianna Greco, Filippo Timpanaro, Tiziana Basile, Antonio Belfiore, Giuseppe Giugno, Andrea Rocca, Roberta Ruggieri, Martino Fiumara, Agata Pavone, Piero Front Neurol Neurology BACKGROUND: Guillain-Barrè syndrome (GBS) is an acute immune-mediated disorder affecting peripheral nerves and nerve roots with a variable clinical course and outcome. Epidemiologic analyses have revealed that the incidence of the syndrome increases linearly among the age. The clinical diagnosis of GBS is based on the family history, physical and neurological examination, electrodiagnostic exams, and cerebrospinal fluid analysis with the classical presence of albumin-cytologic dissociation. Prognosis is associated with the severity of clinical signs and the type of peripheral nerves involved. METHODS: This study aims to clarify which clinical features can be used for prognostic purposes. We evaluated the correlation between (1) brain MRI lesions and grade of disability; (2) brain MRI lesions and elevated cerebrospinal fluid (CSF) protein; and (3) increased levels of CSF protein and grade of disability. Statistical analysis extracted from these data indicated a good correlation to be a prognostic indicator in children affected by GBS. We found little evidence regarding laboratory tests, imaging, and prognosis. We enrolled 12 continuous patients who met the Brighton criteria for GBS in this retrospective study. Each patient was clinically evaluated at the time of disease onset to assess the GBS disability score and after 2 weeks. RESULTS: We estimated Pearson's correlation index to evaluate the possible correlation between MRI and disability and CSF protein levels and disability. The correlation coefficient was 0.92 and 0.85, respectively. In addition, we developed a graph to see the trend of the disability values, proteins in the CSF, and damage assessed with MRI in the 12 patients. It seems that these parameters have a parallel trend and a good correlation in each patient. Finally, we calculated the correlation between MRI and CSF protein values, with an r-value of 0.87. The values suggest a correlation among the MRI score, CSF protein, and prognosis. CONCLUSION: The MRI and CSF laboratory parameters can be important tools for the clinician not only for diagnosis but also to evaluate the possible worsening of general conditions or the need to prepare measures to support life parameters. Patients who need ventilatory support could be established early from patients who have less severe GBS and can begin rehabilitation earlier. We suggest MRI should be performed routinely in children with GBS to be able to estimate the evolution of the clinical condition. Frontiers Media S.A. 2022-10-21 /pmc/articles/PMC9635623/ /pubmed/36341115 http://dx.doi.org/10.3389/fneur.2022.885897 Text en Copyright © 2022 Pizzo, Di Nora, Di Mari, Costanza, Testa, Strazzieri, Greco, Timpanaro, Basile, Belfiore, Giugno, Rocca, Ruggieri, Fiumara and Pavone. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Pizzo, Francesco
Di Nora, Alessandra
Di Mari, Alessia
Costanza, Giuseppe
Testa, Elisabetta
Strazzieri, Marianna
Greco, Filippo
Timpanaro, Tiziana
Basile, Antonio
Belfiore, Giuseppe
Giugno, Andrea
Rocca, Roberta
Ruggieri, Martino
Fiumara, Agata
Pavone, Piero
Case report: Incidence and prognostic value of brain MRI lesions and elevated cerebrospinal fluid protein in children with Guillain-Barré syndrome
title Case report: Incidence and prognostic value of brain MRI lesions and elevated cerebrospinal fluid protein in children with Guillain-Barré syndrome
title_full Case report: Incidence and prognostic value of brain MRI lesions and elevated cerebrospinal fluid protein in children with Guillain-Barré syndrome
title_fullStr Case report: Incidence and prognostic value of brain MRI lesions and elevated cerebrospinal fluid protein in children with Guillain-Barré syndrome
title_full_unstemmed Case report: Incidence and prognostic value of brain MRI lesions and elevated cerebrospinal fluid protein in children with Guillain-Barré syndrome
title_short Case report: Incidence and prognostic value of brain MRI lesions and elevated cerebrospinal fluid protein in children with Guillain-Barré syndrome
title_sort case report: incidence and prognostic value of brain mri lesions and elevated cerebrospinal fluid protein in children with guillain-barré syndrome
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635623/
https://www.ncbi.nlm.nih.gov/pubmed/36341115
http://dx.doi.org/10.3389/fneur.2022.885897
work_keys_str_mv AT pizzofrancesco casereportincidenceandprognosticvalueofbrainmrilesionsandelevatedcerebrospinalfluidproteininchildrenwithguillainbarresyndrome
AT dinoraalessandra casereportincidenceandprognosticvalueofbrainmrilesionsandelevatedcerebrospinalfluidproteininchildrenwithguillainbarresyndrome
AT dimarialessia casereportincidenceandprognosticvalueofbrainmrilesionsandelevatedcerebrospinalfluidproteininchildrenwithguillainbarresyndrome
AT costanzagiuseppe casereportincidenceandprognosticvalueofbrainmrilesionsandelevatedcerebrospinalfluidproteininchildrenwithguillainbarresyndrome
AT testaelisabetta casereportincidenceandprognosticvalueofbrainmrilesionsandelevatedcerebrospinalfluidproteininchildrenwithguillainbarresyndrome
AT strazzierimarianna casereportincidenceandprognosticvalueofbrainmrilesionsandelevatedcerebrospinalfluidproteininchildrenwithguillainbarresyndrome
AT grecofilippo casereportincidenceandprognosticvalueofbrainmrilesionsandelevatedcerebrospinalfluidproteininchildrenwithguillainbarresyndrome
AT timpanarotiziana casereportincidenceandprognosticvalueofbrainmrilesionsandelevatedcerebrospinalfluidproteininchildrenwithguillainbarresyndrome
AT basileantonio casereportincidenceandprognosticvalueofbrainmrilesionsandelevatedcerebrospinalfluidproteininchildrenwithguillainbarresyndrome
AT belfioregiuseppe casereportincidenceandprognosticvalueofbrainmrilesionsandelevatedcerebrospinalfluidproteininchildrenwithguillainbarresyndrome
AT giugnoandrea casereportincidenceandprognosticvalueofbrainmrilesionsandelevatedcerebrospinalfluidproteininchildrenwithguillainbarresyndrome
AT roccaroberta casereportincidenceandprognosticvalueofbrainmrilesionsandelevatedcerebrospinalfluidproteininchildrenwithguillainbarresyndrome
AT ruggierimartino casereportincidenceandprognosticvalueofbrainmrilesionsandelevatedcerebrospinalfluidproteininchildrenwithguillainbarresyndrome
AT fiumaraagata casereportincidenceandprognosticvalueofbrainmrilesionsandelevatedcerebrospinalfluidproteininchildrenwithguillainbarresyndrome
AT pavonepiero casereportincidenceandprognosticvalueofbrainmrilesionsandelevatedcerebrospinalfluidproteininchildrenwithguillainbarresyndrome